FDA review on transgenic salmon too narrow, experts say
Thursday, November 18, 2010 - 15:21
in Health & Medicine
The review process being used by the Food and Drug Administration to assess the safety of a faster-growing transgenic salmon fails to weigh the full effects of the fish's widespread production, according to new analysis.